Early Plasma Reduces Mortality in Traumatic Intracranial Hemorrhage

Traumatic brain injury remains a leading cause of mortality and long-term disability, with intracranial hemorrhage frequently requiring aggressive resuscitation to mitigate secondary neurological damage. Clinical management of these patients necessitates a multidisciplinary approach focused on the rapid correction of coagulopathy and the maintenance of physiological homeostasis [1]. Current consensus guidelines emphasize the importance of organized response plans and the early use of blood products, yet the specific timing and ideal ratios for components like plasma remain subjects of ongoing clinical debate [2]. Systemic complications, such as accidental hypothermia, further complicate the clinical picture by significantly increasing the risk of in-hospital mortality in the setting of head trauma [3]. While advanced diagnostic tools like viscoelastic haemostatic assays (point-of-care tests that measure the physical properties of a clot as it forms to guide transfusion) have been integrated into many trauma centers, their ability to improve survival over standard protocols is still being evaluated [4]. A recent multicenter analysis now provides specific data on how the timing of plasma transfusion directly influences 30-day mortality in this population.